Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free TNGX Stock Alerts

Tango Therapeutics (TNGX) Short Interest Ratio & Short Volume

Tango Therapeutics logo
$27.18 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$27.16 -0.02 (-0.06%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Tango Therapeutics Short Interest Overview

As of July 15, 2026, Tango Therapeutics (TNGX) had a short interest of 42.72 million shares sold short, representing 31.59% of the public float. This marks a 1.69% increase in short interest since the prior report. The short interest ratio (days to cover) is 15.3, meaning it would take 15.3 days of the average trading volume of 2.51 million shares to cover all short positions.

Current Short Interest
42,720,390 shares
Previous Short Interest
42,009,250 shares
Change Vs. Previous Month
1.69%
Dollar Volume Sold Short
$1.29 billion
Short Interest Ratio
15.3 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
144,650,000 shares
Short Percent of Float
31.59%
Today's Trading Volume
1,687,620 shares
Average Trading Volume
2,508,126 shares
Today's Volume Vs. Average
67%
Short Selling Tango Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Tango Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TNGX Short Interest Over Time

TNGX Days to Cover Over Time

TNGX Percentage of Float Shorted Over Time

Tango Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202642,720,390 shares $1.29 billion +1.7%31.6%15.32 $30.25
6/30/202642,009,250 shares $1.31 billion +23.4%31.1%6.59 $31.26
6/15/202634,040,485 shares $1.12 billion +1.7%25.2%5.43 $32.90
5/29/202633,488,854 shares $736.09 million +5.3%24.8%13.01 $21.98
5/15/202631,809,897 shares $654.01 million -16.8%23.5%10 $20.56
4/30/202638,250,843 shares $826.98 million -5.0%28.4%12.51 $21.62
4/15/202640,245,058 shares $1.02 billion -0.3%29.8%14.36 $25.33
3/31/202640,370,279 shares $845.60 million -14.6%29.8%12.09 $20.95
3/13/202647,246,429 shares $817.36 million -3.1%34.9%9.77 $17.30
2/27/202648,739,116 shares $542.95 million +3.6%36.0%18.2 $11.14
2/13/202647,035,092 shares $606.75 million +2.7%34.8%16.21 $12.90
1/30/202645,822,083 shares $531.99 million +7.2%33.9%16.78 $11.61
1/15/202642,753,576 shares $499.79 million +7.0%31.6%12.03 $11.69
12/31/202539,972,307 shares $354.15 million +19.1%29.6%13.49 $8.86
12/15/202533,549,991 shares $305.98 million +0.9%24.8%16.28 $9.12
11/28/202533,248,529 shares $362.91 million +7.9%24.6%9.93 $10.92
11/14/202530,816,336 shares $251.77 million +4.9%24.8%10.34 $8.17
10/31/202529,388,713 shares $238.05 million -19.2%23.6%5.33 $8.10
10/15/202536,350,000 shares $346.05 million +7.5%56.5%13.9 $9.52
9/30/202533,810,000 shares $284.00 million +26.2%52.6%17.2 $8.40
9/15/202526,800,000 shares $182.78 million +5.5%40.4%12.8 $6.82
8/31/202525,400,000 shares $170.43 million +1.0%38.9%12.3 $6.71
8/15/202525,160,000 shares $170.33 million +11.9%40.1%9.6 $6.77
7/31/202522,480,000 shares $135.78 million +4.4%37.2%7.1 $6.04
7/15/202521,530,000 shares $127.24 million +1.6%36.5%7.6 $5.91
6/30/202521,190,000 shares $108.49 million +35.2%36.0%7.8 $5.12
6/15/202515,670,000 shares $73.49 million -1.8%26.6%6.5 $4.69
5/31/202515,950,000 shares $34.77 million +16.0%27.1%7.6 $2.18
5/15/202513,750,000 shares $20.90 million +9.6%23.3%9.5 $1.52
4/30/202512,550,000 shares $17.70 million +11.7%21.2%17.5 $1.41
4/15/202511,240,000 shares $15.46 million +12.0%19.0%15.8 $1.38
3/31/202510,040,000 shares $13.75 million +10.2%17.0%12.6 $1.37
3/15/20259,110,000 shares $17.76 million +29.4%15.4%10.4 $1.95
2/28/20257,040,000 shares $14.57 million +18.5%11.9%7.3 $2.07
2/15/20255,940,000 shares $14.67 million +9.2%12.3%5.9 $2.47
1/31/20255,440,000 shares $16.21 million -22.5%11.0%3.2 $2.98
1/15/20257,020,000 shares $19.31 million -6.3%14.1%3.8 $2.75
12/31/20247,490,000 shares $23.14 million -7.1%15.0%3.9 $3.09
12/15/20248,060,000 shares $24.66 million +11.6%16.3%4.2 $3.06
11/30/20247,220,000 shares $28.45 million +1.6%14.6%3.9 $3.94
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
11/15/20247,110,000 shares $27.37 million -21.7%14.4%3.9 $3.85
10/31/20249,080,000 shares $49.35 million +2.0%14.6%6 $5.44
10/15/20248,900,000 shares $61.50 million -17.7%15.4%9.7 $6.91
9/30/202410,810,000 shares $83.24 million +3.4%18.7%11.9 $7.70
9/15/202410,450,000 shares $109.73 million +2.4%18.1%11.5 $10.50
8/31/202410,210,000 shares $120.78 million +0.9%17.8%11.9 $11.83
8/15/202410,120,000 shares $95.13 million +11.0%17.7%13 $9.40
7/31/20249,120,000 shares $89.83 million +7.4%16.0%12.1 $9.85
7/15/20248,490,000 shares $85.07 million +1.9%15.3%11.7 $10.02
6/30/20248,330,000 shares $71.47 million -15.0%15.1%13 $8.58
6/15/20249,800,000 shares $87.51 million -6.5%17.8%15.6 $8.93
5/31/202410,480,000 shares $72.52 million -1.3%19.0%16.7 $6.92
5/15/202410,620,000 shares $82.84 million -2.5%12.1%17.9 $7.80
4/30/202410,890,000 shares $83.85 million +2.5%19.8%17.7 $7.70
4/15/202410,630,000 shares $77.81 million +4.3%19.4%17.6 $7.32
3/31/202410,190,000 shares $80.91 million +14.8%19.4%14.6 $7.94
3/15/20248,880,000 shares $80.19 million +0.1%16.9%13.4 $9.03
2/29/20248,870,000 shares $98.72 million -7.4%17.7%14.4 $11.13
2/15/20249,580,000 shares $113.24 million -8.9%19.1%15.1 $11.82
1/31/202410,510,000 shares $123.49 million +0.6%20.6%16.2 $11.75
1/15/202410,450,000 shares $114.32 million +2.7%20.5%14.9 $10.94
12/31/202310,180,000 shares $100.78 million +8.2%19.9%9.9 $9.90
12/15/20239,410,000 shares $100.12 million -3.6%18.4%8.3 $10.64
11/30/20239,760,000 shares $74.18 million +4.5%19.2%7.9 $7.60
11/15/20239,340,000 shares $67.57 million +10.7%18.4%7.7 $7.24
10/31/20238,440,000 shares $70.90 million +23.0%16.1%3.3 $8.40
10/15/20236,860,000 shares $52.75 million +29.4%13.0%2.8 $7.69
9/30/20235,300,000 shares $59.68 million +49.7%11.4%2.6 $11.26
9/15/20233,540,000 shares $30.13 million +37.2%7.6%2 $8.51
8/31/20232,580,000 shares $16.74 million -7.9%5.6%1.6 $6.49
8/15/20232,800,000 shares $19.32 million +71.8%6.9%1.7 $6.90
7/31/20231,630,000 shares $5.51 million +8.7%3.8%1.2 $3.38
7/15/20231,500,000 shares $5.15 million -1.3%3.5%7.8 $3.43
6/30/20231,520,000 shares $5.05 million +1.3%3.5%7.3 $3.32
6/15/20231,500,000 shares $5.42 million -18.5%3.5%6.6 $3.61
5/31/20231,840,000 shares $4.97 million +1.1%3.6%8.2 $2.70
5/15/20231,820,000 shares $6.86 million -18.0%3.6%11 $3.77
4/30/20232,220,000 shares $7.55 million -11.9%4.4%11 $3.40
4/15/20232,520,000 shares $10.74 million -2.0%5.0%12 $4.26
3/31/20232,570,000 shares $10.15 million +9.4%5.1%12.8 $3.95
3/15/20232,350,000 shares $10.06 million +2.2%4.7%12.3 $4.28
2/28/20232,300,000 shares $12.03 million +8.0%4.6%11 $5.23
2/15/20232,130,000 shares $12.10 million +43.9%4.2%9.6 $5.68
1/31/20231,480,000 shares $9.77 million +3.5%2.9%7.2 $6.60
1/15/20231,430,000 shares $11.53 million -2.1%2.9%7.1 $8.06
12/30/20221,460,000 shares $10.59 million +33.9%2.9%6.8 $7.25
12/15/20221,090,000 shares $8.63 million -14.8%2.2%5.1 $7.92
11/30/20221,280,000 shares $9.61 million -0.8%2.8%5.8 $7.51
11/15/20221,290,000 shares $10.45 million +3.2%2.9%6.1 $8.10
10/31/20221,250,000 shares $10.05 million +13.6%2.8%6.2 $8.04
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
10/15/20221,100,000 shares $5.69 million +3.8%2.4%5.1 $5.17
9/30/20221,060,000 shares $3.84 million -24.3%2.4%4.8 $3.62
9/15/20221,400,000 shares $5.01 million +7.7%3.1%4 $3.58
8/31/20221,300,000 shares $5.33 million -4.4%2.9%3.7 $4.10
8/15/20221,360,000 shares $7.33 million -16.1%3.0%3.4 $5.39
7/31/20221,620,000 shares $6.63 million -3.0%3.6%4 $4.09
7/15/20221,670,000 shares $7.53 million -8.7%3.7%4.2 $4.51
6/30/20221,830,000 shares $8.29 million +81.2%4.1%4.9 $4.53
6/15/20221,010,000 shares $4.13 million +3.8%2.2%2.6 $4.09
5/31/2022973,300 shares $6.51 million -14.6%2.2%3.2 $6.69
5/15/20221,140,000 shares $5.78 million -63.2%2.5%4.3 $5.07
4/30/20223,100,000 shares $22.82 million +3.0%6.9%12.6 $7.36
4/15/20223,010,000 shares $23.00 million -2.9%6.7%13 $7.64
3/31/20223,100,000 shares $23.50 million +40.3%6.9%13.9 $7.58
3/15/20222,210,000 shares $19.51 million +5.2%4.9%11.3 $8.83
2/28/20222,100,000 shares $19.24 million No Change4.7%15.3 $9.16
2/15/20222,100,000 shares $19.64 million No Change5.3%15 $9.35
1/31/20222,100,000 shares $17.91 million +1.9%5.3%12.9 $8.53
1/15/20222,060,000 shares $17.80 million -10.4%5.2%12.4 $8.64
12/31/20212,300,000 shares $25.16 million -2.1%5.8%15.3 $10.94
12/15/20212,350,000 shares $25.76 million -6.4%5.9%14.9 $10.96
11/30/20212,510,000 shares $26.03 million +16.2%6.3%11 $10.37
11/15/20212,160,000 shares $29.16 million +64.9%5.4%9.5 $13.50
10/29/20211,310,000 shares $16.82 million -7.1%3.7%6.4 $12.84
10/15/20211,410,000 shares $19.78 million -6.6%4.0%7.3 $14.03
9/30/20211,510,000 shares $19.52 million +365.6%4.3%7.9 $12.93
9/15/2021324,300 shares $5.13 million +593.0%0.9%1.9 $15.83
8/31/202146,800 shares $542.41 thousand +4.2%0.1%0.6 $11.59
8/13/202144,900 shares $0.00 No Change0.1%1.1 $0.00

TNGX Short Interest - Frequently Asked Questions

Short interest is the volume of Tango Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 42,720,390 shares of TNGX short. 31.59% of Tango Therapeutics' shares are currently sold short. Learn More on Tango Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNGX shares currently have a short interest ratio of 15.3. Learn More on Tango Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 31.59% of Tango Therapeutics' floating shares are currently sold short.

Tango Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 42,720,390 shares, an increase of 1.7% from the previous total of 42,009,250 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

31.59% of Tango Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Tango Therapeutics: Elanco Animal Health Incorporated (7.25%), Axsome Therapeutics, Inc. (7.40%), Arrowhead Pharmaceuticals, Inc. (7.10%), Abivax SA Sponsored ADR (4.61%), Krystal Biotech, Inc. (13.65%), Summit Therapeutics PLC (29.15%), Cytokinetics, Incorporated (14.07%), Nuvalent, Inc. (0.95%), Dr. Reddy's Laboratories Ltd (2.56%), Crinetics Pharmaceuticals, Inc. (6.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling TNGX is an investing strategy that aims to generate trading profit from Tango Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tango Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNGX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNGX, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TNGX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:TNGX) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel